Washington, D.C., November 17, 2025– The ERISA Industry Committee (ERIC) today urged the U.S. Patent and Trademark Office (USPTO) to withdraw a proposed rule revising procedures of the Patent Trial and Appeal Board (PTAB) saying the proposal contradicts President Trump’s stated priority to make prescription drugs more affordable for American patients.
Miscellaneous Archives:
ERIC: Biosimilars Can Help Employers Lower Costs Without Compromising Care
Washington, D.C., November 14, 2025– In a new report released today by The ERISA Industry Committee (ERIC), a majority of member companies stated they would consider shifting away from the “Traditional Rebate Model” if they were able to achieve savings by including lower list price drugs like biosimilars on their formulary.
ERIC and More than 100 Groups: Don’t Repeat History, Enact PBM Reform
Washington, D.C., November 12, 2025– The ERISA Industry Committee (ERIC) and more than 100 stakeholder groups representing employers, workers, patients, providers, consumers, industry stakeholders, and more, today called on Congress to act with urgency to enact strong pharmacy benefit manager (PBM) reforms this year.
ERIC Statement on Trump Administration Announcement to Accelerate Biosimilar Development and Lower Drug Costs
Washington, D.C., October 29, 2025–The ERISA Industry Committee (ERIC) issued the following statement today regarding the Trump Administration’s announcement to make it faster and less costly to develop biosimilar medicines. The statement can be attributed to ERIC President and CEO, James Gelfand.
Employers Issue Warning: Broken Surprise Billing Law Hurts Patients and Threatens Affordable Health Coverage
The ERISA Industry Committee (ERIC) and employee benefit industry groups today urged The U.S. Departments of Labor, Health and Human Services, and Treasury (the Tri-Departments) to take immediate action to address severe negative consequences of the Independent Dispute Resolution (IDR) process under the No Surprises Act.
ERIC President and CEO James Gelfand Named a Top Lobbyist of 2025
Washington, D.C., October 23, 2025– Today, The ERISA Industry Committee (ERIC) announced that its President and CEO, James Gelfand, has been named one of the Top 100 Lobbyists in the U.S. by the National Institute for Lobbying & Ethics (NILE), an organization representing lobbying, public policy, and government affairs professionals. Gelfand and the other 2025 recipients will be honored on November 3rd during a reception in Washington, D.C.
Employers Recognize Improvements to California PBM Legislation Recently Signed Into Law – Will Monitor Regulatory Process to Ensure Proper Implementation
Washington, D.C., October 15, 2025– Dillon Clair, Director of State Advocacy for The ERISA Industry Committee (ERIC), issued the statement below following Governor Newsom’s signing of Senate Bill 41 to reform the practices of Pharmacy Benefit Managers (PBMs) across California. During the legislative process, ERIC worked closely with lawmakers to ensure the bill would not interfere with the design and administration of self-funded health benefit plans governed by the federal Employee Retirement Income Security Act of 1974 (“ERISA”).
ERIC Applauds Dismissal of Bueno v. General Electric
Washington, D.C., September 24, 2025– The ERISA Industry Committee (ERIC) applauded today’s dismissal of Bueno v. General Electric (GE).
PBM Reform Bill Reflects Effort to Balance State Oversight with ERISA Uniformity
Washington, D.C., September 15, 2025– The ERISA Industry Committee expressed appreciation today for efforts taken by the California State Legislature to amend SB 41 and avoid conflict with federally-governed, self-insured ERISA plans. The bill, which aims to address rising prescription drug costs by regulating the network and reimbursement practices of pharmacy benefit managers (PBMs), is now structured to uphold the uniformity and flexibility that employers have to design and administer multi-state plans under the Employee Retirement Income Security Act (“ERISA”). Both the Assembly and the Senate adopted the legislation unanimously after amendments were reconciled, and it has been sent to Governor Newsom (D-CA), who has until October 13 to sign the bill or issue a veto.
Employers Urge Appeals Court to Uphold Lower Court Ruling, Blocking Tennessee Law That Threatens Health Benefits
Washington, D.C., September 8, 2025– On Friday, September 5, The ERISA Industry Committee (ERIC) and aligned organizations filed an amicus brief in the U.S. Court of Appeals for the Sixth Circuit in McKee Foods Corporation v. BFP, Inc. (McKee).